John Maki

John Maki is a strategic advisor at ConSynance Therapeutics. Prior to joining ConSynance, John was the managing director of the Audax Group, a multi-asset class private equity group. Prior to that, they were a principal at Bain Capital, a private equity group. Prior to that, they were a consultant at Bain & Company, a management consulting company. Prior to that, they were the CEO of Bayesian Biotech. Prior to that, they were the CEO of Jade River Pharma. Prior to that, they were the managing director of TDI. Prior to that, they were a research assistant at the National Bureau of Economic Research.

John Maki graduated from Harvard University with a degree in economics, magna cum laude.